ProShares Ultra NASDAQ Biotechnology
41 hedge funds and large institutions have $24.1M invested in ProShares Ultra NASDAQ Biotechnology in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 4 closing their positions.
Holders
41
Holders Change
+1
Holders Change %
+2.5%
% of All Funds
0.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
12
Reduced
8
Closed
4
Calls
$15.9M
Puts
$21.6M
Net Calls
-$5.67M
Net Calls Change
-$896K